(Q36684187)

15 August 2017

1 reference

title

Statins and biomarkers of inflammation (English)

1 reference

15 August 2017

0 references

Sridevi Devaraj

1

1 reference

PubMed ID

17169243

15 August 2017

Jason Rogers

series ordinal

2

1 reference

PubMed ID

17169243

15 August 2017

Ishwarlal Jialal

series ordinal

3

1 reference

15 August 2017

1 January 2007

1 reference

Current Atherosclerosis Reports

15 August 2017

1 reference

15 August 2017

9

1 reference

15 August 2017

33-41

1 reference

15 August 2017

1

1 reference

https://scigraph.springernature.com/pub.10.1007/bf02693938

15 August 2017

0 references

cites work

C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction

1 reference

https://api.crossref.org/works/10.1007%2FBF02693938

Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02693938

Effect of hydroxymethyl glutaryl coenzyme a reductase inhibitor therapy on high sensitive C-reactive protein levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02693938

Rapid reduction in C-reactive protein with cerivastatin among 785 patients with primary hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02693938

Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02693938

Vastatins Inhibit Tissue Factor in Cultured Human Macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02693938

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

21 January 2018

1 reference

12 December 2020

HMG-CoA reductase inhibitors regulate inflammatory transcription factors in human endothelial and vascular smooth muscle cells

1 reference

12 December 2020

Statins reduce inflammation in atheroma of nonhuman primates independent of effects on serum cholesterol

1 reference

12 December 2020

Simvastatin, an HMG-coenzyme A reductase inhibitor, improves endothelial function within 1 month

1 reference

12 December 2020

Statins promote potent systemic antioxidant effects through specific inflammatory pathways

1 reference

12 December 2020

High-sensitivity C-reactive protein: a novel and promising marker of coronary heart disease

1 reference

12 December 2020

Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events

1 reference

12 December 2020

Statin induction of liver fatty acid-binding protein (L-FABP) gene expression is peroxisome proliferator-activated receptor-alpha-dependent

1 reference

12 December 2020

Statin therapy, lipid levels, C-reactive protein and the survival of patients with angiographically severe coronary artery disease

1 reference

12 December 2020

Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: phase Z of the A to Z trial

1 reference

12 December 2020

ARBITER: Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol: a randomized trial comparing the effects of atorvastatin and pravastatin on carotid intima medial thickness

1 reference

12 December 2020

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

1 reference

12 December 2020

Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study

1 reference

12 December 2020

Simvastatin reduces expression of cytokines interleukin-6, interleukin-8, and monocyte chemoattractant protein-1 in circulating monocytes from hypercholesterolemic patients.

1 reference

12 December 2020

Lipoprotein-associated phospholipase A2 as a biomarker for coronary disease and stroke

1 reference

12 December 2020

Fibrate and statin synergistically increase the transcriptional activities of PPARalpha/RXRalpha and decrease the transactivation of NFkappaB.

1 reference

12 December 2020

Rosuvastatin in the primary prevention of cardiovascular disease among patients with low levels of low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive protein: rationale and design of the JUPITER trial

1 reference

12 December 2020

Myeloperoxidase and cardiovascular disease.

1 reference

12 December 2020

Effects of statins on vascular wall: vasomotor function, inflammation, and plaque stability

1 reference

12 December 2020

Cholesterol reduction rapidly improves endothelial function after acute coronary syndromes. The RECIFE (reduction of cholesterol in ischemia and function of the endothelium) trial

1 reference

12 December 2020

Short-term effects of atorvastatin on C-reactive protein

1 reference

12 December 2020

Differential hs-CRP reduction in patients with familial hypercholesterolemia treated with aggressive or conventional statin therapy

1 reference

12 December 2020

Association of nitrotyrosine levels with cardiovascular disease and modulation by statin therapy

1 reference

12 December 2020

Strong decrease of high sensitivity C-reactive protein with high-dose atorvastatin in patients with type 2 diabetes mellitus

1 reference

12 December 2020

HMG-CoA Reductase Inhibitors Decrease CD11b Expression and CD11b-Dependent Adhesion of Monocytes to Endothelium and Reduce Increased Adhesiveness of Monocytes Isolated From Patients With Hypercholesterolemia

1 reference

12 December 2020

Simvastatin preserves coronary endothelial function in hypercholesterolemia in the absence of lipid lowering

1 reference

12 December 2020

Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease

1 reference

12 December 2020

Diverse effects of inhibition of 3-hydroxy-3-methylglutaryl-CoA reductase on the expression of VCAM-1 and E-selectin in endothelial cells

1 reference

12 December 2020

Statins selectively inhibit leukocyte function antigen-1 by binding to a novel regulatory integrin site

1 reference

12 December 2020

Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels

1 reference

12 December 2020

Single LDL apheresis improves endothelium-dependent vasodilatation in hypercholesterolemic humans

1 reference

12 December 2020

Endothelial function and coronary artery disease

1 reference

12 December 2020

Inflammation and atherosclerosis: the value of the high-sensitivity C-reactive protein assay as a risk marker

1 reference

12 December 2020

High-dose atorvastatin enhances the decline in inflammatory markers in patients with acute coronary syndromes in the MIRACL study

1 reference

12 December 2020

Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease

1 reference

12 December 2020

Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association

1 reference

12 December 2020

Lipoprotein-associated phospholipase A2 and its association with cardiovascular outcomes in patients with acute coronary syndromes in the PROVE IT-TIMI 22 (PRavastatin Or atorVastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infar

1 reference

12 December 2020

Modulation of inflammatory mediators and PPARgamma and NFkappaB expression by pravastatin in response to lipoproteins in human monocytes in vitro

1 reference

12 December 2020

Nitrotyrosine and chlorotyrosine: clinical significance and biological functions in the vascular system

1 reference

12 December 2020

Differential inhibition of macrophage foam-cell formation and atherosclerosis in mice by PPARalpha, beta/delta, and gamma

1 reference

12 December 2020

Inhibitory effect of fluvastatin, an HMG-CoA reductase inhibitor, on the expression of adhesion molecules on human monocyte cell line

1 reference

12 December 2020

Effects of fluvastatin and bezafibrate combination on plasma fibrinogen, t-plasminogen activator inhibitor and C reactive protein levels in coronary artery disease patients with mixed hyperlipidaemia (FACT study). Fluvastatin Alone and in [...]

1 reference

12 December 2020

Clinical relevance of C-reactive protein during follow-up of patients with acute coronary syndromes in the Aggrastat-to-Zocor Trial

1 reference

12 December 2020

Atorvastatin lowers C-reactive protein and improves endothelium-dependent vasodilation in type 2 diabetes mellitus

1 reference

12 December 2020

HMG-CoA reductase inhibition by atorvastatin reduces neointimal inflammation in a rabbit model of atherosclerosis

1 reference

12 December 2020

Effect of simvastatin on monocyte adhesion molecule expression in patients with hypercholesterolemia

1 reference

12 December 2020

Reduction in serum cholesterol with pravastatin improves endothelium-dependent coronary vasomotion in patients with hypercholesterolemia

1 reference

12 December 2020

C-reactive protein levels and outcomes after statin therapy

1 reference

12 December 2020

Inflammation in atherosclerosis

1 reference

12 December 2020

Effects of simvastatin (40 and 80 mg) on highly sensitive C-reactive protein in patients with combined hyperlipidemia

1 reference

12 December 2020

Serum cholesterol levels and six-year mortality from stroke in 350,977 men screened for the multiple risk factor intervention trial

1 reference

12 December 2020

Role of C-reactive protein in the assessment of cardiovascular risk

1 reference

12 December 2020

Premature mortality from coronary heart disease. The Framingham study

1 reference

12 December 2020

Influence of pravastatin and plasma lipids on clinical events in the West of Scotland Coronary Prevention Study (WOSCOPS)

1 reference

12 December 2020

Is C-reactive protein an innocent bystander or proatherogenic culprit? C-reactive protein promotes atherothrombosis.

1 reference

12 December 2020

Beyond lipid lowering: the role of statins in vascular protection

1 reference

12 December 2020

Effect of simvastatin therapy on endothelial function of hypercholesteremic patients with syndrome X

1 reference

12 December 2020

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

1 reference

12 December 2020

Long-term effects of pravastatin on plasma concentration of C-reactive protein. The Cholesterol and Recurrent Events (CARE) Investigators

1 reference

12 December 2020

C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women

1 reference

12 December 2020

C-reactive protein and the 10-year incidence of coronary heart disease in older men and women: the cardiovascular health study

1 reference

12 December 2020

Simvastatin inhibits the monocyte expression of proinflammatory cytokines in patients with hypercholesterolemia

1 reference

12 December 2020

Hmg-CoA reductase inhibitor modulates monocyte-endothelial cell interaction under physiological flow conditions in vitro: involvement of Rho GTPase-dependent mechanism

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02693938

1 reference

15 August 2017

1 reference

PubMed ID

17169243